M
Medtech Acquisition Corp
NASDAQ:MTAC
Medtech Acquisition Corp
NASDAQ:MTAC
Price:
11.34 USD
18.62%
Market Closed
Updated:
May 5, 2024
Medtech Acquisition Corp
Operating Income
|
Medtech Acquisition Corp
Operating Income Peer Comparison
Comparables:
N
KIND
CVII
SYM
RUM
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
M
|
Medtech Acquisition Corp
NASDAQ:MTAC
|
Operating Income
-$2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
N
|
Nextdoor Holdings Inc
NYSE:KIND
|
Operating Income
-$161.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Churchill Capital Corp VII
NYSE:CVII
|
Operating Income
-$6.6m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Symbotic Inc
NASDAQ:SYM
|
Operating Income
-$220.9m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Rumble Inc
NASDAQ:RUM
|
Operating Income
-$134.4m
|
CAGR 3-Years
-381%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Medtech Acquisition Corp's Operating Income?
Operating Income
-2.7m
USD
-2.7m
USD
Based on the financial report for Dec 31, 2022, Medtech Acquisition Corp's Operating Income amounts to -2.7m USD.
What is Medtech Acquisition Corp's Operating Income growth rate?
Operating Income CAGR 1Y
10%
10%
Over the last year, the Operating Income growth was 10%.
You don't have any saved screeners yet
